American Heart Journal
Volume 153, Issue 1 , Pages 66.e1-66.e8 , January 2007

Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction

  • Hendrik-Jan Dieker, MD

      Affiliations

    • Department of Cardiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • John K. French, MB, ChB, PhD, FACC

      Affiliations

    • Department of Cardiology, Green Lane Cardiovascular Research Unit, Green Lane Cardiovascular Service Auckland City Hospital, Auckland, New Zealand
    • Department of Cardiology, Liverpool Hospital, Sydney, Australia
    • Corresponding Author InformationReprint requests: John K. French, MB, ChB, PhD, FACC, Cardiology Department, Liverpool Hospital, Locked Bag 7103, Liverpool BC1871 NSW, Australia.
    • ,
  • Irene C. Joziasse, MD

      Affiliations

    • Department of Cardiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Marc A. Brouwer, MD, PhD

      Affiliations

    • Department of Cardiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • John Elliott, MB, ChB, PhD

      Affiliations

    • Department of Medicine, Christchurch School of Medicine, Christchurch Hospital, Christchurch, New Zealand
    • ,
  • Teena M. West, BSc

      Affiliations

    • Department of Cardiology, Green Lane Cardiovascular Research Unit, Green Lane Cardiovascular Service Auckland City Hospital, Auckland, New Zealand
    • ,
  • Bruce J. Webber, MH Sc

      Affiliations

    • Department of Cardiology, Green Lane Cardiovascular Research Unit, Green Lane Cardiovascular Service Auckland City Hospital, Auckland, New Zealand
    • ,
  • Freek W.A. Verheugt, MD, PhD, FACC

      Affiliations

    • Department of Cardiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Harvey D. White, MB, ChB, DSc, FACC

      Affiliations

    • Department of Cardiology, Green Lane Cardiovascular Research Unit, Green Lane Cardiovascular Service Auckland City Hospital, Auckland, New Zealand

Received 16 February 2006 ,Accepted 8 October 2006.

References 

  1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86
  2. Ohman EM, Califf RM, Topol EJ, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. Circulation. 1990;82:781–791
  3. Gibson CM, Karha J, Murphy SA, et al. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials. J Am Coll Cardiol. 2003;42:7–16
  4. Roux S, Christeller S, Lüdin E. Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis. J Am Coll Cardiol. 1992;19:671–677
  5. Meijer A, Verheugt FWA, Werter CJPJ, et al. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study: results of the APRICOT Study. Circulation. 1993;87:1524–1530
  6. White HD, French JK, Hamer AW, et al. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. J Am Coll Cardiol. 1995;25:218–223
  7. Yokoya K, Takatsu H, Suzuki T, et al. Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis. A study based on four serial coronary arteriograms per year. Circulation. 1999;100:903–909
  8. Burke AP, Kolodgie FD, Farb A, et al. Healed plaque ruptures and sudden coronary death. Evidence that subclinical rupture has a role in plaque progression. Circulation. 2001;103:934–940
  9. De Feyter PJ, Ozaki Y, Baptista J, et al. Ischemia-related lesion characteristics in patients with stable or unstable angina: a study with intracoronary angioscopy and ultrasound. Circulation. 1995;92:1408–1413
  10. Chesebro JH, Webster MWI, Zoldhelyi P, et al. Antithrombotic therapy and progression of coronary artery disease. Antiplatelet versus antithrombins. Circulation. 1992;86:III100–III110
  11. White HD, Norris RM, Brown MA, et al. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med. 1987;317:850–855
  12. White HD, Rivers JT, Maslowski AH, et al. Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction. N Engl J Med. 1989;320:817–821
  13. CASS investigators . A multicenter comparison of the effects of randomized medical and surgical treatment of mildly symptomatic patients with coronary artery disease, and a registry of consecutive patients undergoing coronary angiography. Circulation. 1981;63(Suppl I):I1–I81
  14. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44–51
  15. French JK, Ellis CJ, Webber BJ, et al. Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected thrombolysis in myocardial infarction (TIMI) frame court and stenosis severity. Am J Cardiol. 1998;81:665–671
  16. Ormiston JA, Stewart FM, Roche AH, et al. Late regression of the dilated site after angioplasty: a 5-year quantitative angiographic study. Circulation. 1997;96:468–474
  17. Waters D, Pedersen TR. Review of cholesterol-lowering therapy: coronary angiographic and events trials. Am J Med. 1996;101(Suppl 4A):34s–39s
  18. Califf RM, Pieper KS, Lee KL, et al. Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation. 2000;101:2231–2238
  19. Goldman S, Copeland J, Moritz T, et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation. 1988;77:1324–1332
  20. van der Meer J, Hillege HL, van Gilst WH, et al. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. Lancet. 1993;342:257–264
  21. Ericsson CG, Hamsten A, Nilsson J, et al. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet. 1996;347:849–853
  22. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004;291:1071–1080
  23. Waters D, Craven TE, Lesperance J. Prognostic significance of progression of coronary atherosclerosis. Circulation. 1993;87:1067–1075
  24. Azen SP, Mack WJ, Cashin-Hemphill L, et al. Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation. 1996;93:34–41
  25. Fox KM and the European trial on reduction of cardiac events with perindopril in stable coronary artery disease investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782–788
  26. GISSI-Prevenzione Investigators . Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447–455
  27. Cashin-Hemphill L, Holmvang G, Chan RC, et al. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. Am J Cardiol. 1999;83:43–47
  28. Sacks FM, Stone PH, Gibson CM, et al. Controlled trial of fish oil for regression of human coronary atherosclerosis. J Am Coll Cardiol. 1995;25:1492–1498
  29. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371–1375
  30. Goldstein JA, Demetriou D, Grines Cl, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343:915–922

 None of the authors have any conflict of interest in connection with this work.

PII: S0002-8703(06)00894-5

doi: 10.1016/j.ahj.2006.10.006

American Heart Journal
Volume 153, Issue 1 , Pages 66.e1-66.e8 , January 2007

Article Tools

* Image Usage & Resolution